Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modigraf PK in Pediatric Liver and Kidney Transplant
NCT05152628Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2022
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus + Wuzhi capsule in Liver transplant rejection and kidney transplant rejection (2 arms), sponsored by Astellas Pharma. Primary endpoints: Area under the blood concentration - time curve for a dosing interval on Day 1, Area under the blood concentration - time curve for a dosing interval on Day 7 and 7 more. Started Jan 2022; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
Liver transplant rejectionkidney transplant rejection
Beyond the preview
Go deeper on NCT05152628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05152628.